Company intelligence / Profile preview

NIL Technology

Kongens Lyngby, Capital Region/Kongens Lyngby, Denmarkgivetoathletics.com ↗

Ownership: Private
Employees: ~176
Development stage: Other

Overview

NILT is a leader in nanoimprint lithography and mass production of nanostructured surfaces. The company has developed high-fidelity metallic nanostructure arrays used in transmission surface-plasmon resonance (TSPR) diagnostics. In collaboration with leading biotech partners, it is enabling next-generation blood-based tests for Alzheimer’s disease that are non-invasive and cost-effective compared to current standards like PET scans. Its core business also includes commercial supply of advanced meta-optical elements.

Therapeutic areas: Neurology
Modalities: DeviceNanostructured surface technologyMeta-optics
Industry: Protein Biomarker Diagnostics

Partnerships

Undisclosed leading biotech company on Alzheimer's blood test platform development

Beyond the preview

Go deeper on NIL Technology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on NIL Technology.

Explore the full profile